Bong yKoh's Net Worth
$660 Million
Who is Bong yKoh?
Bong yKoh has an estimated net worth of $660 Million. This is based on reported shares across multiple companies, which include Shockwave Medical, Inc., KalVista Pharmaceuticals, Inc., CONSTELLATION PHARMACEUTICALS INC, Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., AveXis, Inc., ARCA biopharma, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Avalanche Biotechnologies, Inc..
SEC CIK
Bong yKoh's CIK is 0001615979
Past Insider Trading and Trends
2022 was Bong yKoh's most active year for acquiring shares with 46 total transactions. Bong yKoh's most active month to acquire stocks was the month of May. 2018 was Bong yKoh's most active year for disposing of shares, totalling 7 transactions. Bong yKoh's most active month to dispose stocks was the month of September. 2019 saw Bong yKoh paying a total of $13,899,999.90 for 4,786,899 shares, this is the most they've acquired in one year. In 2019 Bong yKoh cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.06% | 400K |
$34.50 | $13,800,000.00 | 4.02M |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Shockwave Medical, Inc. (SWAV) Snapshot price: $235.415
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.12M |
—
|
—
| 2.12M |
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.525
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +1.82% | 86.05K |
$14.62 | $1,257,828.78 | 4.82M |
Feb 6 - Feb 8
| |||
Form 4
| +1.89% | 88.1K |
$14.47 | $1,274,792.53 | 4.74M |
Jan 30
| |||
Form 4
| +2.01% | 91.8K |
$14.05 | $1,289,802.42 | 4.65M |
Jan 25 - Jan 29
| |||
Form 4
| +2.22% | 99.13K |
$12.53 | $1,241,684.52 | 4.56M |
Jan 22 - Jan 24
| |||
Form 4
| +3.33% | 143.6K |
$12.55 | $1,801,601.80 | 4.46M |
Jan 17 - Jan 19
| |||
Form 4
| +0.61% | 26.25K |
$12.72 | $333,779.23 | 4.32M |
Jan 11 - Jan 16
| |||
Form 4
| +3.32% | 137.7K |
$12.54 | $1,726,456.92 | 4.29M |
Jan 8 - Jan 10
| |||
Form 4
| +1.45% | 59.37K |
$12.14 | $720,543.04 | 4.15M |
Jan 3 - Jan 4
| |||
Form 4
| +14.52% | 519.02K |
$12.46 | $6,465,649.95 | 4.09M |
Dec 27 - Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -24.46% | -500.00K |
$28.75 | -$14,375,000.00 | 1.54M |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Altimmune, Inc. (ALT) Snapshot price: $10.445
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.22% | -1.00M |
—
|
—
| 3.5M |
Feb 25
| |||
Form 4
| +50.00% | 1.5M |
$7.54 | $11,310,000.00 | 4.5M |
Jun 15
| |||
Form 4
| +76.85% | 1.3M |
$8.74 | $11,395,493.13 | 3M |
May 26 - May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Unum Therapeutics Inc. (COGT) Snapshot price: $5.865
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.55% | 451K |
$2.52 | $1,137,120.00 | 4.36M |
Aug 14 - Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |